NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill may restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests a new medicine called zasocitinib for adults with nonsegmental vitiligo, a condition where the immune system attacks skin pigment cells, causing white patches. About 200 participants will receive either the drug or a placebo for up to a year. The goal is to see i…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 17, 2026 05:54 UTC
-
New cream could help kids with vitiligo regain skin color
Disease control Recruiting nowThis study tests a cream called ruxolitinib in children aged 6 to 12 with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely bring back color, especially on the face. About 250 children will take part, and they mus…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Promising cream may help kids with vitiligo regain skin color
Disease control Recruiting nowThis study tests a cream called ruxolitinib in 180 children with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely bring back color, especially on the face. Participants will apply the cream daily for several mont…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC
-
Could a tanning drug help restore skin color in vitiligo?
Disease control Recruiting nowThis study tests whether adding an investigational drug called Melanotan II to standard light therapy can help restore skin color in adults with stable vitiligo. About 60 participants will receive either the drug or a placebo, along with light treatments, to see if the combinatio…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC